Transcriptomic studies identified distinct mutations including somatic mutations in <i>GNAQ</i> and <i>GNA11</i>, detected in more than 80%, and contribute to the upregulation of the mitogen-activated protein kinase (MAPK) pathway and the development of uveal melanoma (UM). Here, WNK2 is linked to uveal melanoma.